HomeHealthcare & Life SciencesPharmaceuticals Myasthenia Gravis Treatment Market

Argentina Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033


Argentina Myasthenia Gravis Treatment Market Insights

  • Based on Reed Intelligence findings, the Argentina Myasthenia Gravis Treatment Market reached USD 14.59 Million in 2024 and is estimated to attain USD 34.1 Million by 2033.
  • From 2026 to 2033, the Argentina market is expected to grow at a steady CAGR of 9.83%.
  • Within the By Type category, Ocular MG  dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Ocular MG  is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

Other Key Findings


  • Argentina accounted for 0.69% of the global Myasthenia Gravis Treatment Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within LATAM, Brazil is forecasted to dominate the regional Myasthenia Gravis Treatment Market size by 2033.
  • Chile will be the fastest-growing market in LATAM, projected to achieve USD 28.08 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 14.59 Million
Market Size In 2033 USD 34.1 Million
Largest segment Ocular MG 
Units Revenue in USD Million
CAGR 9.83% (2025-2033)
Segmnetation Covered
By Type
  1. Ocular MG 
  2. Congenital MG 
  3. Transient Neonatal MG
By Treatment
  1. Medication 
  2. Surgery 
  3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
  4. Plasmapheresis and Intravenous Immunoglobulin 
  5. Others
By End-User
  1. Hospitals 
  2. Clinics 
  3. Academic Research Institutes 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports